Skip to search boxSkip to navigationSkip to main content

Evidence for redundancy in propeptide/prohormone convertase activities in processing proglucagon: An antisense study

  • Mark E. Rothenberg
    ,
  • Carmen D. Eilertson
    ,
  • Kathy Klein
    ,
  • ,
  • Bryan D. Noe(corresponding author)
*Corresponding author for this work
  • Emory University
    ,
  • Creighton University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>To further examine the physiological roles of the neuroendocrine prohormone convertases (PCs) in proglucagon processing, αTC1-6 cells were transiently transfected with PC1/3 and PC2 expression vectors containing either antisense or sense encoding cDNAs. PC1/3- and PC2-directed RIAs were used to determine that the PC1/3 antisense transfections lowered endogenous levels of PC1/3 by 40 ± 7.9% but did not alter the levels of PC2. The PC2 antisense transfections decreased the endogenous levels of PC2 by 91 ± 11.7% without affecting the levels of PC1/3. To quantitate the levels of proglucagon and proglucagon-derived products, transfected cells were metabolically labeled with [<sup>3</sup>H]tryptophan, and extracts were chromatographed by reversed-phase HPLC. Recovered peptides were then subjected to peptide mapping analyses, allowing precise quantification of <sup>3</sup>H-radioactivity incorporated into proglucagon and its cleavage products. Product-precursor ratios were determined, and percent change in the proportion of products generated in antisense-transfected vs. sense-transfected cells was calculated. The decrease in PC1/3 after antisense treatment significantly reduced the amounts of glicentin produced and partially reduced the levels of all other proglucagon cleavage products. PC2 antisense treatment significantly reduced the levels of glicentin and 9K glucagon generated but had no significant effect on the remainder of the proglucagon-derived peptides. These results suggest the existence of redundant mechanisms that ensure the production of each of the intermediate and product peptides derived from proglucagon. PC1/3 is potentially an important enzyme in the processing of most proglucagon-derived peptides, whereas PC2-processing activity appears to predominate at only two of the four potential cleavage sites.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 331-341 (11 pages)

Journal (Volume, Issue Number)

Molecular Endocrinology (Volume 10, Issue 4)

Publication milestones

  • Published - 1996

Publication status

Published - 1996

ISSN

0888-8809

Publication IDs

  • Scopus: 0029925365
  • PubMed: 8721979

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
SciVal
FWCI
1.01
SciVal
Author count
5
SciVal
citations
28
SciVal
Paper percentile
79

PlumX, opens in new tab

Captures
6
Citation count
28

Funding Details

FunderFunding number
NIDDK
R01DK044986